Xintela Competitors and Similar CompaniesClear all

Xintela's competitors and similar companies include Joint Academy, Ribon Therapeutics and Peptomyc.
Xintela
Xintela
Xintela is a biomedical company working in the fields of regenerative medicine and cancer.
Joint Academy
Joint Academy
Joint Academy (also known as Arthro Therapeutics) is a digital clinic for patients with osteoarthritis.
Ribon Therapeutics
Ribon Therapeutics
Ribon Therapeutics discovers and develops novel small molecule therapeutics for major unmet medical needs.
Peptomyc
Peptomyc
Peptomyc is a company focused on the development of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment.
Founding Date
Founding Date
2009
Founding Date
2014
Founding Date
2015
Founding Date
2014
Type
Type
Public
Type
Subsidiary
Type
Private
Type
Private
Tags
Locations
Locations
Lund, SE HQ
Lund, SE
Lund, SE
Locations
Malmö, SE HQ
New York, US
Locations
Cambridge, US HQ
Locations
Barcelona, ES HQ
Employees
Employees
15
Employees
983% decrease
Employees
614% decrease
Employees
20

Financial

Revenue (est.)
Revenue (est.)
kr2.3m (FY, 2025)
Revenue (est.)
kr62.4m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
kr39.8m (FY, 2020)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
kr2.3m (FY, 2025)
Gross profit
kr22.6m (FY, 2020)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
(kr48.6m) (FY, 2025)
Net income
(kr33.8m) (FY, 2020)
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 934.5k
Total funding raised
$ 33.2m
Total funding raised
$ 65m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Joint Academy
HQ
Malmö, SE

Joint Academy (also known as Arthro Therapeutics) is a digital clinic for patients with osteoarthritis.

View company
Ribon Therapeutics
HQ
Cambridge, US
Employees
6↓ 14% decrease

Ribon Therapeutics discovers and develops novel small molecule therapeutics for major unmet medical needs.

View company
Peptomyc
HQ
Barcelona, ES
Employees
20

Peptomyc is a company focused on the development of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment.

View company